Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 22;19(1):23.
doi: 10.1186/s13023-023-02986-x.

Developing a community-led rare disease ELSI research agenda

Collaborators, Affiliations
Review

Developing a community-led rare disease ELSI research agenda

Courtney Berrios et al. Orphanet J Rare Dis. .

Abstract

Background: Research priorities are best defined through engagement with communities who will be impacted by the research and have lived experience of the topics to be studied. We aimed to establish a pediatric rare disease community stakeholder group and empower them in (1) eliciting perspectives from affected families in the wider region and (2) synthesizing collective ideas into a research agenda focused on shared ethical, legal, and social implications (ELSI) across rare disease.

Methods: This two-year project utilized a community-centered approach to engage rare disease community members as equal partners in developing a research agenda for ELSI in rare disease. We established "Rare Voices" (RV), a 22-member stakeholder group of patients, parents, clinicians and researchers. Following capacity-building trainings, RV designed and conducted listening sessions with teen patients and parents of children with rare diseases to explore challenges, positive experiences, and ethical concerns. Listening session findings were synthesized and contextualized into research topics, which RV members further refined and prioritized. We used established measures to assess RV member engagement and satisfaction.

Results: From 14 listening sessions with parents (n = 52) and teen patients (n = 13), RV identified eight core research topics as most important for future rare disease research: coordinating care, communication, accessing resources and care, impact on family unit, community and support in society, mental health and identity, ethical aspects of care, and uncertainty. RV members were highly engaged throughout the two-year project and reported high levels of satisfaction with the experience and research agenda.

Conclusions: Through capacity-building and authentic engagement, this project resulted in a community-led rare disease research agenda to guide future rare disease ELSI research that aligns with patients' and families' priorities. An environment of equal partnership and respect created a space for mutual learning where community members were empowered to shape the research agenda based on their collective experiences. The agenda recognizes the shared psychosocial and healthcare experiences of rare disease and offers practical areas of research to address patient and family needs.

Keywords: Community engagement; ELSI; Rare disease; Research agenda.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Overview of project design and timeline
Fig. 2
Fig. 2
Community feedback survey responses (n = 37) indicating agreement with research agenda developed by Rare Voices
Fig. 3
Fig. 3
Results of RV engagement evaluation responses to the 9 items on the condensed REST using a 4-point Likert scale (very good to poor) and an option for not applicable for each item. T1 = after RV training was complete (n = 18), T2 = after listening sessions were completed (n = 19), T3 = at project completion (n = 15)

References

    1. Caldwell WB, Reyes AG, Rowe Z, Weinert J, Israel BA. Community partner perspectives on benefits, challenges, facilitating factors, and lessons learned from community-based participatory research partnerships in Detroit. Prog Community Health Partnersh. 2015;9(2):299–311. doi: 10.1353/cpr.2015.0031. - DOI - PubMed
    1. Shen S, Doyle-Thomas KAR, Beesley L, Karmali A, WilliamsL, Tanel N, McPherson AC. How and why should we engage parents as co-researchers in health research? A scoping review of current practices. Health Expectations.2017;20(4):543–554. - PMC - PubMed
    1. Sprague Martinez L, Carolan K, O'Donnell A, Diaz Y, Freeman ER. Community engagement in patient-centered outcomes research: Benefits, barriers, and measurement. Journal of Clinical and Transational Science. 2018;2(6):371–376. doi: 10.1017/cts.2018.341. - DOI - PMC - PubMed
    1. Merkel PA, Manion M, Gopal-Srivastava R, Groft S, Jinnah HA, Robertson D, et al. The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis. 2016;11:66. doi: 10.1186/s13023-016-0445-8. - DOI - PMC - PubMed
    1. Ainsworth C. Rare diseases band together toward change in research. Nat Med. 2020;26(10):1496–1499. doi: 10.1038/s41591-020-1098-7. - DOI - PubMed